Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GlaxoSmithKline Tells Execs to Leave Nonprofit Selling Resveratrol Supplements .
WSJ
Saturday, August 14, 2010 - 12:28pm
tags:
reserveratrol, GSK, Sirtuin
Kendall Law Group Investigates Trubion Pharmaceuticals, Inc. Acquisition for Shareholders
Yahoo/BusinessWire
Saturday, August 14, 2010 - 12:24pm
tags:
Trubion, legal, M&A
Nasdaq Grants Repros Extension until October 31, 2010 to Meet Minimum Bid Price Listing Requirement
Yahoo/BusinessWire
Saturday, August 14, 2010 - 12:22pm
tags:
Repros Therapeutics
BioSante Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Saturday, August 14, 2010 - 12:20pm
tags:
BioSante, investors
Cell Second Quarter Net Loss Widens
Yahoo/Zacks
Saturday, August 14, 2010 - 12:19pm
tags:
Cell Therapeutics, earnings, investors
Trubion shares skyrocket after Emergent deal announced
bizjournals
Saturday, August 14, 2010 - 12:16pm
tags:
Trubion, Emergent BioSolutions, arthritis, lupus, non-Hodgkin's lymphoma, leukemia
PDL tumbles on Roche patent dispute
Marketwatch
Friday, August 13, 2010 - 12:03pm
tags:
PDL Biopharma, Roche, patents, Europe, Avastin, Herceptin, Lucentis, Xolair
Is pharma marketing ready for its digital close-up?
Fierce Pharma
Friday, August 13, 2010 - 11:56am
tags:
pharma marketing, e-marketing
Marginal Performance at Alcon
Motley Fool
Friday, August 13, 2010 - 11:52am
tags:
JNJ, Merck, Alcon, Eli Lilly, Ista
Is Gilead Sciences Growing Foolishly?
Motley Fool
Friday, August 13, 2010 - 9:22am
tags:
Gilead Sciences, Merck, Genzyme
Compugen Goes the Extra Mile in Drug Discovery
Seeking Alpha
Friday, August 13, 2010 - 9:20am
tags:
drug discovery, CompuGen
Emergent buys Trubion for up to $135M
Fierce Biotech
Friday, August 13, 2010 - 9:20am
tags:
Emergent BioSolutions, Trubion, M&A
Genzyme’s Takeover Defense Against Sanofi Is Its Own Incompetence
BNET Pharma
Friday, August 13, 2010 - 9:17am
tags:
Genzyme, M&A, Sanofi
Sanofi-Aventis Forges Research Alliance to Expand Pipeline Sources
Seeking Alpha
Friday, August 13, 2010 - 9:15am
tags:
Sanofi, Scripps Health, partnerships, R&D
The FDA Probes Glaxo Over Avandia Disclosures
Pharmalot
Friday, August 13, 2010 - 7:41am
tags:
FDA, Avandia, GSK, diabetes
Simcere 2Q earnings climb nearly 4 pct to $5.7M
Yahoo/AP
Friday, August 13, 2010 - 7:38am
tags:
earnings, Simcere
U.S. District Court Rules Against Lilly Regarding Strattera Patent
Yahoo
Friday, August 13, 2010 - 7:29am
tags:
patents, Eli Lilly, Strattera
US probes corruption in big pharma
FT.com
Friday, August 13, 2010 - 7:27am
tags:
DOJ, Merck, GSK, Pfizer, Bristol-Myers Squibb, Eli Lilly, SEC
Johnson & Johnson and the Bond Bubble
Seeking Alpha
Friday, August 13, 2010 - 7:25am
tags:
JNJ, bonds
Glaxo Slaps Former Sirtris Execs
TheStreet.com
Friday, August 13, 2010 - 7:22am
tags:
GSK, Sirtris

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.